Curia CDMO is a leading global contract research, development, and manufacturing organization with over 30 years of experience in the pharmaceutical and biotech industry. We are committed to improving patients' lives by offering end-to-end services that accelerate the journey from idea to impact. With a flexible suite of R&D and manufacturing capabilities, Curia combines deep scientific expertise and state-of-the-art technology to ensure every stage of the process advances quickly and accurately.

From discovery to manufacturing, launch to commercialization, we leverage our industry-leading knowledge to deliver high-quality therapies that make a difference. Curia's capabilities span various areas, including biologics research and development, manufacturing, and lab testing. We offer services such as antibody discovery and engineering, stable CHO cell line development, formulation development, analytical development, and more.

At Curia, we understand that science goes beyond numbers. We balance the science of impact with the art of possibility, collaborating with our partners to not only deliver therapies but also change lives for the better. Experience the expertise and innovation of Curia CDMO as we continue to make significant contributions to the pharmaceutical and biotech field